Globus Medical Inc - Understand $gmed stock

$GMED Market Cap: $11.49 Billion

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$2.479B

TTM

Gross Margin

58.15%

TTM

Net Earnings

$91.51M

TTM

Current Assets

$2.057B

Q3 2024

Current Liabilities

$818.1M

Q3 2024

Current Ratio

251.39%

Q3 2024

Total Assets

$5.086B

Q3 2024

Total Liabilities

$1.017B

Q3 2024

Book Value

$4.069B

Q3 2024

Cash

$622.8M

Q3 2024

P/E

125.6

Nov 29, 2024 EST

Free Cash Flow

$293.8M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Revenue	$1.568B	$1.023B	$958.1M	$789.0M	$785.4M	$713.0M	$636.0M	$564.0M	$544.8M	$474.4M	$434.5M	$386.0M	$331.5M	$288.2M	$254.3M	$176.8M
YoY Change	53.34%	6.76%	21.43%	0.47%	10.15%	12.11%	12.76%	3.53%	14.84%	9.19%	12.56%	16.45%	15.02%	13.33%	43.83%	44.21%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Revenue	$1.568B	$1.023B	$958.1M	$789.0M	$785.4M	$713.0M	$636.0M	$564.0M	$544.8M	$474.4M	$434.5M	$386.0M	$331.5M	$288.2M	$254.3M	$176.8M
Cost Of Revenue	$548.2M	$263.7M	$239.2M	$217.5M	$180.0M	$159.4M	$150.5M	$134.7M	$132.3M	$110.8M	$100.3M	$75.20M	$68.80M	$53.83M	$41.60M	$33.80M
Gross Profit	$1.020B	$759.1M	$718.9M	$571.6M	$605.4M	$553.6M	$485.5M	$429.3M	$412.4M	$363.6M	$334.1M	$310.8M	$262.7M	$234.4M	$212.7M	$143.0M
Gross Profit Margin	65.05%	74.22%	75.03%	72.44%	77.08%	77.64%	76.34%	76.12%	75.71%	76.65%	76.9%	80.52%	79.25%	81.32%	83.64%	80.88%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Selling, General & Admin	$643.4M	$432.1M	$408.1M	$354.8M	$354.8M	$311.6M	$267.8M	$222.2M	$210.2M	$188.6M	$182.5M	$168.9M	$140.4M	$122.6M	$108.4M	$85.50M
YoY Change	48.9%	5.87%	15.05%	0.0%	13.85%	16.34%	20.55%	5.67%	11.46%	3.35%	8.09%	20.28%	14.52%	13.09%	26.78%	18.59%
% of Gross Profit	63.06%	56.92%	56.78%	62.07%	58.6%	56.29%	55.16%	51.75%	50.98%	51.88%	54.63%	54.33%	53.44%	52.31%	50.96%	59.79%
Research & Development	$124.0M	$73.02M	$97.35M	$84.52M	$60.07M	$55.50M	$43.68M	$44.53M	$36.31M	$31.17M	$26.87M	$27.93M	$23.46M	$21.31M	$20.50M	$15.30M
YoY Change	69.84%	-24.99%	15.18%	40.69%	8.25%	27.05%	-1.92%	22.64%	16.51%	15.99%	-3.78%	19.02%	10.11%	3.95%	33.99%	8.51%
% of Gross Profit	12.15%	9.62%	13.54%	14.79%	9.92%	10.03%	9.0%	10.37%	8.8%	8.57%	8.04%	8.99%	8.93%	9.09%	9.64%	10.7%
Depreciation & Amortization	$144.7M	$68.25M	$69.87M	$62.87M	$52.73M	$41.63M	$42.07M	$38.77M	$24.08M	$21.75M	$19.40M	$18.11M	$16.95M	$15.20M	$13.50M
YoY Change	112.06%	-2.31%	11.12%	19.23%	26.67%	-1.04%	8.5%	60.98%	10.71%	12.15%	7.12%	6.84%	11.54%	12.56%
% of Gross Profit	14.19%	8.99%	9.72%	11.0%	8.71%	7.52%	8.66%	9.03%	5.84%	5.98%	5.81%	5.83%	6.45%	6.48%	6.35%
Operating Expenses	$887.2M	$531.2M	$546.9M	$460.1M	$433.4M	$384.2M	$323.7M	$275.1M	$240.2M	$225.2M	$232.4M	$196.0M	$165.3M	$146.7M	$128.9M	$100.8M
YoY Change	67.02%	-2.88%	18.86%	6.17%	12.8%	18.71%	17.64%	14.55%	6.64%	-3.1%	18.59%	18.56%	12.7%	13.8%	27.88%	16.94%
Operating Profit	$133.1M	$228.0M	$172.0M	$111.4M	$172.0M	$169.3M	$161.8M	$154.1M	$172.2M	$138.4M	$101.7M	$114.8M	$97.36M	$87.69M	$83.80M	$42.20M
YoY Change	-41.59%	32.57%	54.31%	-35.21%	1.57%	4.62%	4.99%	-10.5%	24.47%	36.09%	-11.43%	17.9%	11.04%	4.64%	98.58%	358.7%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Interest Expense	$34.39M	$13.21M	$7.874M	$13.70M	$17.50M	$13.60M	$7.500M	$2.600M	$100.0K	-$100.0K	-$300.0K	-$100.0K	-$400.0K	$200.0K
YoY Change	160.27%	67.81%	-42.53%	-21.71%	28.68%	81.33%	188.46%	2500.0%	-200.0%	-66.67%	200.0%	-75.0%	-300.0%
% of Operating Profit	25.83%	5.8%	4.58%	12.29%	10.18%	8.03%	4.63%	1.69%	0.06%	-0.07%	-0.3%	-0.09%	-0.41%	0.23%
Other Income/Expense, Net	$32.25M	$15.07M	$8.454M	$14.47M	$17.96M	$19.28M	$8.088M	$3.138M	$583.0K	$280.0K	$328.0K	-$140.0K	-$413.0K	$54.00K	-$100.0K	$300.0K
YoY Change	114.04%	78.24%	-41.56%	-19.44%	-6.86%	138.38%	157.74%	438.25%	108.21%	-14.63%	-334.29%	-66.1%	-864.81%	-154.0%	-133.33%	-137.5%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Pretax Income	$165.4M	$243.0M	$180.4M	$125.9M	$189.9M	$180.7M	$155.1M	$154.4M	$171.3M	$137.6M	$101.4M	$114.2M	$97.68M	$87.54M	$81.80M	$36.40M
YoY Change	-31.94%	34.71%	43.3%	-33.72%	5.12%	16.54%	0.44%	-9.87%	24.44%	35.71%	-11.17%	16.89%	11.58%	7.02%	124.73%	-842.86%
Income Tax	$42.52M	$52.85M	$31.22M	$23.61M	$34.74M	$32.13M	$62.58M	$52.94M	$60.02M	$46.16M	$33.39M	$40.82M	$36.17M	$33.28M	$29.70M	$15.30M
% Of Pretax Income	25.71%	21.75%	17.3%	18.76%	18.29%	17.78%	40.36%	34.29%	35.04%	33.53%	32.92%	35.75%	37.03%	38.02%	36.31%	42.03%
Net Earnings	$122.9M	$190.2M	$149.2M	$102.3M	$155.2M	$156.5M	$107.3M	$104.3M	$112.8M	$92.49M	$68.61M	$73.83M	$60.78M	$54.46M	$48.70M	$19.00M
YoY Change	-35.39%	27.47%	45.86%	-34.1%	-0.81%	45.76%	2.88%	-7.49%	21.95%	34.79%	-7.07%	21.46%	11.62%	11.82%	156.32%	-363.89%
Net Earnings / Revenue	7.83%	18.59%	15.57%	12.96%	19.76%	21.95%	16.88%	18.5%	20.7%	19.5%	15.79%	19.13%	18.34%	18.9%	19.15%	10.75%
Basic Earnings Per Share	$1.09	$1.89	$1.48	$1.04	$1.57	$1.60	$1.12	$1.09	$1.19	$0.98	$0.74	$0.82	$0.69	$0.61
Diluted Earnings Per Share	$1.07	$1.85	$1.44	$1.01	$1.52	$1.54	$1.10	$1.08	$1.17	$0.97	$0.73	$0.80	$0.67	$0.60	$198.6K	$77.84K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Cash & Short-Term Investments	$517.8M	$446.1M	$443.4M	$426.7M	$311.5M	$339.7M	$373.7M	$290.3M	$281.0M	$228.7M	$238.9M	$212.4M	$142.7M	$111.7M
YoY Change	16.08%	0.59%	3.92%	36.98%	-8.3%	-9.1%	28.73%	3.31%	22.87%	-4.27%	12.48%	48.84%	27.75%
Cash & Equivalents	$467.3M	$150.5M	$193.1M	$239.4M	$195.7M	$139.7M	$118.8M	$132.6M	$60.20M	$82.30M	$90.00M	$212.4M	$142.7M	$111.7M
Short-Term Investments	$50.50M	$295.6M	$250.4M	$187.3M	$115.8M	$199.9M	$254.9M	$157.7M	$220.9M	$146.4M	$149.0M
Other Short-Term Assets	$44.58M	$21.00M	$18.42M	$17.80M	$17.20M	$15.40M	$11.20M	$15.00M	$72.20M	$69.10M	$42.40M	$26.80M	$18.70M	$17.80M
YoY Change	112.32%	14.01%	3.47%	3.49%	11.69%	37.5%	-25.33%	-79.22%	4.49%	62.97%	58.21%	43.32%	5.06%
Inventory	$848.1M	$299.0M	$237.0M	$229.2M	$196.3M	$131.3M	$108.4M	$112.7M	$105.3M	$90.90M	$70.40M	$62.30M	$47.40M	$40.90M
Prepaid Expenses
Receivables	$503.2M	$213.2M	$164.4M	$141.7M	$154.3M	$137.1M	$116.7M	$92.00M	$77.70M	$75.40M	$62.40M	$53.50M	$46.70M	$42.40M
Other Receivables	$1.635M	$4.061M	$1.215M	$6.400M	$8.100M	$7.300M	$10.40M	$3.800M	$8.700M	$5.800M	$2.700M	$5.100M	$3.400M	$6.200M
Total Short-Term Assets	$1.915B	$983.3M	$864.5M	$821.8M	$687.5M	$630.7M	$620.3M	$513.8M	$544.8M	$470.0M	$416.8M	$360.1M	$258.8M	$219.0M
YoY Change	94.78%	13.75%	5.2%	19.53%	9.01%	1.68%	20.73%	-5.69%	15.91%	12.76%	15.75%	39.14%	18.17%
Property, Plant & Equipment	$646.9M	$243.7M	$226.1M	$221.6M	$202.3M	$171.9M	$143.2M	$124.2M	$114.7M	$69.50M	$64.20M	$61.10M	$52.40M	$45.90M
YoY Change	165.4%	7.8%	2.03%	9.54%	17.68%	20.04%	15.3%	8.28%	65.04%	8.26%	5.07%	16.6%	14.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$75.43M	$495.9M	$562.5M	$358.5M	$409.5M	$263.1M	$56.10M	$60.40M	$48.80M	$75.30M	$36.50M
YoY Change	-84.79%	-11.84%	56.9%	-12.45%	55.64%	368.98%	-7.12%	23.77%	-35.19%	106.3%
Other Assets	$89.28M	$92.16M	$55.81M	$33.90M	$25.20M	$23.90M	$28.00M	$31.60M	$600.0K	$1.000M	$900.0K	$1.000M	$1.000M	$1.700M
YoY Change	-3.13%	65.13%	64.63%	34.52%	5.44%	-14.64%	-11.39%	5166.67%	-40.0%	11.11%	-10.0%	0.0%	-41.18%
Total Long-Term Assets	$3.171B	$1.093B	$1.093B	$857.7M	$844.6M	$670.0M	$458.2M	$413.8M	$289.3M	$233.5M	$149.5M	$87.00M	$70.60M	$47.60M
YoY Change	190.15%	0.0%	27.4%	1.55%	26.06%	46.22%	10.73%	43.03%	23.9%	56.19%	71.84%	23.23%	48.32%
Total Assets	$5.086B	$2.076B	$1.957B	$1.680B	$1.532B	$1.301B	$1.079B	$927.6M	$834.1M	$703.5M	$566.3M	$447.1M	$329.4M	$266.6M
YoY Change
Accounts Payable	$56.67M	$36.10M	$21.96M	$18.20M	$24.60M	$25.90M	$25.00M	$17.50M	$16.00M	$21.30M	$12.70M	$12.50M	$6.500M	$7.300M
YoY Change	56.98%	64.43%	20.63%	-26.02%	-5.02%	3.6%	42.86%	9.38%	-24.88%	67.72%	1.6%	92.31%	-10.96%
Accrued Expenses	$252.4M	$94.71M	$91.17M	$78.30M	$63.30M	$59.90M	$52.60M	$46.40M	$53.80M	$61.50M	$51.10M	$25.00M	$21.30M	$18.80M
YoY Change	166.54%	3.88%	16.43%	23.7%	5.68%	13.88%	13.36%	-13.75%	-12.52%	20.35%	104.4%	17.37%	13.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$5.300M
YoY Change													-100.0%
Long-Term Debt Due	$475.0K
YoY Change
Total Short-Term Liabilities	$392.3M	$159.2M	$140.2M	$120.8M	$111.4M	$96.10M	$93.10M	$79.90M	$82.70M	$89.40M	$67.90M	$39.50M	$29.30M	$31.70M
YoY Change	146.44%	13.58%	16.03%	8.44%	15.92%	3.22%	16.52%	-3.39%	-7.49%	31.66%	71.9%	34.81%	-7.57%
Long-Term Debt	$417.4M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$194.0M	$68.77M	$71.40M	$46.20M	$12.20M	$10.90M	$7.000M	$7.800M	$22.80M	$23.50M	$19.60M	$13.40M	$11.90M	$3.800M
YoY Change	182.04%	-3.68%	54.54%	278.69%	11.93%	55.71%	-10.26%	-65.79%	-2.98%	19.9%	46.27%	12.61%	213.16%
Total Long-Term Liabilities	$611.4M	$68.77M	$71.40M	$46.20M	$12.20M	$10.90M	$7.000M	$7.800M	$22.80M	$23.50M	$19.60M	$13.40M	$11.90M	$3.800M
YoY Change	788.99%	-3.68%	54.54%	278.69%	11.93%	55.71%	-10.26%	-65.79%	-2.98%	19.9%	46.27%	12.61%	213.16%
Total Liabilities	$1.088B	$229.8M	$215.9M	$173.2M	$129.6M	$115.2M	$110.7M	$95.60M	$118.8M	$118.1M	$93.90M	$60.60M	$46.90M	$38.40M
YoY Change	373.61%	6.43%	24.64%	33.64%	12.5%	4.07%	15.79%	-19.53%	0.59%	25.77%	54.95%	29.21%	22.14%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Basic Shares Outstanding	113.1M	100.5M	100.7M	98.58M	99.15M	97.88M	96.24M	95.65M shares	95.05M shares	94.23M shares	92.65M shares	89.61M shares	88.11M shares	88.93M shares
Diluted Shares Outstanding	114.6M	102.6M	103.6M	101.0M	102.0M	101.3M	97.89M	96.43M shares	96.07M shares	95.46M shares	94.19M shares	92.21M shares	90.42M shares	91.35M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $11.494 Billion

About GLOBUS MEDICAL INC

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 5,000 full-time employees. The company went IPO on 2012-03-08. The firm offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. The company provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. The company includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

Industry: Surgical & Medical Instruments & Apparatus Peers: ABBOTT LABORATORIES ABIOMED INC QuidelOrtho Corp Envista Holdings Corp HOLOGIC INC Inspire Medical Systems, Inc. MASIMO CORP Penumbra Inc Shockwave Medical, Inc. TELEFLEX INC